Tag: abcl

AbCellera Biologics Inc. (ABCL) is rated STRONG SELL as valuation still assumes a much faster clinical and commercial ramp than current results support. Despite a large cash balance, ongoing cash burn and rich revenue multiples leave little margin of safety.

Read note